June 5, 2024 Quanterix to Present at 45th Annual Goldman Sachs Global Healthcare Conference read more
May 22, 2024 Quanterix to Present at Leerink Partners Healthcare Crossroads Conference 2024 read more
May 17, 2024 Q&A: Blood-based biomarker testing ‘scientific consensus favorite’ for AD detection read more
January 26, 2024 Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer’s Disease Pathology read more
October 3, 2023 Ultrasensitive immunoassay technology drives blood-based biomarkers for Alzheimer’s disease read more